Substandard and falsified medicines kill quietly, at scale. RxLoop puts guidance, reporting and adherence in the patient's hand, in five Nigerian languages, with no connection required.
RxLoop gives guidance a person can read in their own language, captures a report when a pack looks wrong, and keeps a course on schedule. All of it runs offline.
The patient side stays free permanently. Revenue comes from the actors who gain operational value from the return path, and none of it involves selling individual health data.
| Who | What they get | Basis | Status |
|---|---|---|---|
| Patients | Reference guidance, offline access, reporting and reminders in five languages. | Free, permanently | Live |
| Pharmacies | Batch alerts on packs their own customers flagged, plus stock and dispensing records. | Per outlet, monthly | Pilot stage |
| Manufacturers | Confirm a pack against their own serialisation data. See where imitations surface first. | Usage-based licence | Needs partner |
| Regulators | Anonymised clusters of suspect reports, ahead of formal reporting channels. | Public-interest tier | Needs backend |
The sequencing matters: the patient app has to be genuinely useful with no partners at all, or there is nothing to bring a manufacturer to the table with. That is why the offline reference layer shipped first and the computer-vision verification has not shipped at all.
Building RxLoop from Nigeria, for the pharmacies, patients and regulators who live with this problem daily rather than read about it in a market report.
Co-founder of RxLoop, building it from Nigeria alongside Uzoma with the same aim: put a way to check medicine in the hands of the person taking it.